3rd Annual RAD Conference - December 11-13, 2021
Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.
Our Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.
This activity is intended for physicians, registered nurses and other healthcare providers engaged in the care of patients with Atopic Dermatitis.
After completing this activity, upon diagnosis and assessment of severity of AD, the participant should be better able to:
- Select evidence-based treatment approaches for atopic dermatitis
- Use improved understanding of pathophysiology, disease course and current, available treatment options in therapeutic decision making for atopic dermatitis and related comorbidities
- Identify the remaining unmet needs in the treatment of atopic dermatitis
- Discuss emerging therapies in the treatment of atopic dermatitis
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Foundation for Dermatology Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 19.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 19.5 contact hours.
|Group||Early Bird Rates
(through October 31, 2021)
|November 1, 2021 –
November 30, 2021
|December 1, 2021 –
December 12, 2021
|Physicians and Fellows||US$ 125||US$ 250||US$ 400|
|NPs, PAs, and Nurses||US$ 100||US$ 200||US$ 300|
|Residents and Students||US$ 75||US$ 150||US$ 200|
|Industry – Exhibits and Scientific Sessions||US$ 350||US$ 500||US$ 750|
If you are a patient or member of the media, and you are interested in attending the Conference,
please contact Patrice Melluso: firstname.lastname@example.org